Simulation training as a response to the demand of critical patients COVID19: safety and quality of care
Main Article Content
Abstract
Coronavirus Disease (COVID-19), also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first described in December 2019 in Wuhan, China. It has spread across all continents and was declared by the World Health Organization (WHO), on March 11, 2020, as a global pandemic. On June 24, 2020, 9,129,146 cases and 473,797 deaths from SARS-CoV-2 / COVID 19 were reported by the WHO. The virus is transmitted through droplets, although it has also been found in feces and blood, thus allowing other means of potential transmission. The symptoms associated with SARS-CoV -2 infection include fever, myalgia or fatigue, productive cough or non-productive cough dyspnoea, fatigue, or myalgia in most cases. There are also reports of symptoms such as headache, sore throat, hemoptysis and gastrointestinal symptoms such as diarrhea, nausea and abdominal pain, but with less incidence.
Article Details
Authors maintain copyright and grant the HSJ the right to first publication. From 2024, the publications wiil be licensed under Attribution 4.0 International , allowing their sharing, recognizing the authorship and initial publication in this journal.
Authors are authorized to assume additional contracts separately for the non-exclusive distribution of the version of the work published in this journal (e.g., publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
Authors are encouraged to publish and distribute their work online (e.g., in institutional repositories or on their personal page) at any point after the editorial process.
Also, the AUTHOR is informed and consents that the HSJ can incorporate his article into existing or future scientific databases and indexers, under the conditions defined by the latter at all times, which will involve, at least, the possibility that the holders of these databases can perform the following actions on the article.
References
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. doi: 10.1001/jama.2020.1585.
World Health Organization (2020a) [Internet]. Coronavirus disease 2019 (COVID-19) Situation report – 156 [cited 2020 Jun 25]. Avaiable from: www.who.int/docs/default-source/coronaviruse/situation-reports/20200624-covid-19-sitrep-156.pdf?sfvrsn=af42e480_2
Del Rio C, Malani PN. COVID-19 — new insights on a rapidly changing epidemic. JAMA. 2020;323(14):1339-40. doi: 10.1001/jama.2020.3072
Ziehr DR, Alladina J, Petri CR, Maley JH, Moskowitz A, Medoff BD, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med. 2020; 201(12):1560-4. doi: 10.1164/rccm.202004-1163LE
Möhlenkamp S, Thiele H. Ventilation of COVID-19 patients in intensive care units. Herz. 2020;45:329-31. doi: 10.1007/s00059-020-04923-1
Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656-7. doi: 10.1016/S1473-3099(20)30232-2
Lopez RA, Anthony A, Zuo L, Enomoto TM, Aziz MF. Your COVID-19 intubation kit. Anesth Analg. 2020;131(1):e28-30. doi: 10.1213/ANE.0000000000004855
Muret-Wagstaff SL, Collins JS, Mashman DL, Patel SG, Pettorini K, Rosen SA, et al. In situ simulation enables operating room agility in the COVID-19 pandemic. Ann Surg. 2020 [published 2020 May 20]. [Epub ahead of print]. doi: 10.1097/SLA.0000000000004056
Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases. Lancet Respir Med. 2020;8(5):518-26. doi: 10.1016/S2213-2600(20)30121-1
Fregene TE, Nadarajah P, Buckley JF, Bigham S, Nangalia V. Use of in situ simulation to evaluate the operational readiness of a high‐consequence infectious disease intensive care unit. Anaesth. 2020;75(6):733-8. doi: 10.1111/anae.15048